Dr Stein on the Development of Targeted Therapies in Splicin

Eytan M. Stein, MD, discusses the ongoing development and investigation of therapies targeting splicing mutations in hematologic malignancies.

Related Keywords

Japan , Eytanm Stein , , Division Of Hematologic Malignancies , Memorial Sloan Kettering Cancer Center , Leukemia Service , Program For Drug Development In Leukemia , Drug Development , Hematologic Malignancies , Aim Leukemia , Onclive Tv , Aml , Mds , Emavusertib Formerly Ca 4948 , Irak4 , Clk Inhibitor ,